Reply To: Bortezomib During DI for T Cell Lymphoma

  • Katherine Trimble

    May 5, 2022 at 3:14 pm

    HI Breanne,
    We have a newly diagnosed patient with T-cell lymphoma. WE are planning to give the bortezomib 1.4.8 and 11.
    We are having difficulty getting insurance approval. BCBS. We did a peer to peer.  Send references.
    Did you have difficulty? Do you have any suggestions?
    Thank you,
    Kathy Trimble MSN, RN, CPNP
    Pediatric Hematology/Oncology Nurse Practitioner 
    Northwestern Medicine Central DuPage Hospital
    Winfield, IL

    Katherine Trimble, CPHON,CPNP,MSN,RN
    Pediatric Oncology Nurse Educator
    Winfield, IL
    United States
    Original Message:
    Sent: 05-05-2022 12:48 PM
    From: Breanne Roche
    Subject: Bortezomib During DI for T Cell Lymphoma


    I was wondering what institutions are using bortezomib during DI for T Cell lymphoma patients. If you are using it, are you giving it on Days 1, 4, 8, & 11?



    Breanne Roche, DNP, RN, CPNP
    Pediatric Nurse Practitioner
    Rainbow Babies & Children’s Hospital
    Cleveland, Ohio